Insulin-dependent leptin expression in breast cancer cells

Area of Science:

• Endocrinology
• Molecular Biology
• Oncology

Background:

• Hyperinsulinemia is linked to increased breast cancer risk.
• Leptin, an obesity hormone, promotes breast cancer progression.

Purpose of the Study:

• To investigate the molecular mechanisms by which insulin stimulates leptin expression in breast cancer cells.
• To elucidate the role of transcription factors and signaling pathways in insulin-induced leptin production.

Main Methods:

• Utilized MDA-MB-231 breast cancer cells.
• Measured leptin mRNA and protein expression.
• Analyzed leptin gene promoter activity.
• Assessed nuclear accumulation and promoter binding of transcription factors (HIF-1alpha, Sp1).
• Employed small interfering RNA (siRNA) for gene knockdown.
• Inhibited key signaling pathways (ERK1/2, PI-3K).

Main Results:

• Insulin significantly increased leptin mRNA and protein expression, activating the leptin gene promoter.
• Insulin enhanced nuclear translocation and promoter binding of HIF-1alpha and Sp1.
• Knockdown of HIF-1alpha or Sp1, individually or combined, reduced insulin-induced leptin expression.
• Inhibition of ERK1/2 and PI-3K pathways partially decreased insulin-dependent leptin expression.
• ERK1/2 inhibition reduced binding of both HIF-1alpha and Sp1, while PI-3K inhibition affected HIF-1alpha binding.

Conclusions:

• Hyperinsulinemia may promote breast cancer via leptin-dependent mechanisms.
• Insulin-induced leptin gene transcription in breast cancer cells is mediated by Sp1 and HIF-1alpha.
• The PI-3K and ERK1/2 signaling pathways partially regulate this process.